Literature DB >> 23663482

Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma.

Won-Sik Shin1, Junhye Kwon, Hae Won Lee, Moon Chul Kang, Hye-Won Na, Seung-Taek Lee, Jong Ho Park.   

Abstract

Esophageal squamous cell carcinoma (ESCC) is a common subtype of esophageal cancer that is particularly prevalent in East Asian countries. Our previous expression profile analysis showed that the gene encoding protein tyrosine kinase 7 (PTK7) is upregulated in ESCC tissues. Here, we aimed to validate PTK7 as a prognostic factor and a candidate target for molecular treatment of ESCC. Both RT-PCR and Western blot analysis of tissues from ESCC patients revealed that PTK7 was significantly upregulated in tumor tissue samples of ESCC. Immunohistochemical staining of PTK7 showed that increased expression of PTK7 was inversely correlated with overall survival (P = 0.021). In vitro knockdown of PTK7 inhibited proliferation, survival, wound healing, and invasion of ESCC cells. In addition, PTK7 knockdown decreased phosphorylation of Akt, Erk, and focal adhesion kinase (FAK), important determinants of cell proliferation, survival, and migration. Therefore, our findings suggest that PTK7 has potential as a prognostic marker for ESCC and might also be a candidate for targeted therapy in the treatment of ESCC.
© 2013 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23663482      PMCID: PMC7657253          DOI: 10.1111/cas.12194

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  39 in total

1.  A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.

Authors:  John D Urschel; Hari Vasan
Journal:  Am J Surg       Date:  2003-06       Impact factor: 2.565

Review 2.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

3.  Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE).

Authors:  Philip W Y Chiu; Angus C W Chan; S F Leung; H T Leong; K H Kwong; Micheal K W Li; Alex C M Au-Yeung; Sydney C S Chung; Enders K W Ng
Journal:  J Gastrointest Surg       Date:  2005 Jul-Aug       Impact factor: 3.452

4.  The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome.

Authors:  Thomas Prebet; Anne-Catherine Lhoumeau; Christine Arnoulet; Anaïs Aulas; Sylvie Marchetto; Stéphane Audebert; Francesca Puppo; Christian Chabannon; Danielle Sainty; Marie-Josée Santoni; Michael Sebbagh; Virginia Summerour; Yannick Huon; Won-Sik Shin; Seung-Taek Lee; Benjamin Esterni; Norbert Vey; Jean-Paul Borg
Journal:  Blood       Date:  2010-06-17       Impact factor: 22.113

5.  Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

Authors:  Val Gebski; Bryan Burmeister; B Mark Smithers; Kerwyn Foo; John Zalcberg; John Simes
Journal:  Lancet Oncol       Date:  2007-03       Impact factor: 41.316

6.  Colon carcinoma kinase-4 defines a new subclass of the receptor tyrosine kinase family.

Authors:  K Mossie; B Jallal; F Alves; I Sures; G D Plowman; A Ullrich
Journal:  Oncogene       Date:  1995-11-16       Impact factor: 9.867

7.  Soluble PTK7 inhibits tube formation, migration, and invasion of endothelial cells and angiogenesis.

Authors:  Won-Sik Shin; Yong-Sun Maeng; Jae-Won Jung; Jeong-Ki Min; Young-Guen Kwon; Seung-Taek Lee
Journal:  Biochem Biophys Res Commun       Date:  2008-05-08       Impact factor: 3.575

8.  PTK7/CCK-4 is a novel regulator of planar cell polarity in vertebrates.

Authors:  Xiaowei Lu; Annette G M Borchers; Christine Jolicoeur; Helen Rayburn; Julie C Baker; Marc Tessier-Lavigne
Journal:  Nature       Date:  2004-07-01       Impact factor: 49.962

9.  A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes.

Authors:  S T Lee; K M Strunk; R A Spritz
Journal:  Oncogene       Date:  1993-12       Impact factor: 9.867

10.  The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma.

Authors:  N Iizuka; K Hirose; T Noma; S Hazama; A Tangoku; H Hayashi; T Abe; K Yamamoto; M Oka
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

View more
  24 in total

1.  A meta-analysis of lung cancer gene expression identifies PTK7 as a survival gene in lung adenocarcinoma.

Authors:  Ron Chen; Purvesh Khatri; Pawel K Mazur; Melanie Polin; Yanyan Zheng; Dedeepya Vaka; Chuong D Hoang; Joseph Shrager; Yue Xu; Silvestre Vicent; Atul J Butte; E Alejandro Sweet-Cordero
Journal:  Cancer Res       Date:  2014-03-20       Impact factor: 12.701

2.  PTK7 regulates radioresistance through nuclear factor-kappa B in esophageal squamous cell carcinoma.

Authors:  Misun Park; Hyeon-Joon Yoon; Moon Chul Kang; Junhye Kwon; Hae Won Lee
Journal:  Tumour Biol       Date:  2016-08-24

3.  PTK7 protein is decreased in epithelial ovarian carcinomas with poor prognosis.

Authors:  Haiyan Wang; Guimei Li; Yongxiang Yin; Jianjun Wang; Hai Wang; Wei Wei; Qing Guo; Henghui Ma; Qunli Shi; Xiaojun Zhou; Jiandong Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 4.  Cancer-Associated, Stimuli-Driven, Turn on Theranostics for Multimodality Imaging and Therapy.

Authors:  Xingshu Li; Jihoon Kim; Juyoung Yoon; Xiaoyuan Chen
Journal:  Adv Mater       Date:  2017-03-29       Impact factor: 30.849

5.  Significance of elevated ERK expression and its positive correlation with EGFR in Kazakh patients with esophageal squamous cell carcinoma.

Authors:  Xiaobin Cui; Su Li; Tingting Li; Xuelian Pang; Shumao Zhang; Jing Jin; Jianming Hu; Chunxia Liu; Lan Yang; Hao Peng; Jinfang Jiang; Weihua Liang; Jing Suo; Feng Li; Yunzhao Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

6.  Protein-tyrosine pseudokinase 7 (PTK7) directs cancer cell motility and metastasis.

Authors:  Vladislav S Golubkov; Natalie L Prigozhina; Yong Zhang; Konstantin Stoletov; John D Lewis; Phillip E Schwartz; Robert M Hoffman; Alex Y Strongin
Journal:  J Biol Chem       Date:  2014-07-08       Impact factor: 5.157

7.  Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma.

Authors:  Won-Sik Shin; Junhye Kwon; Hae Won Lee; Moon Chul Kang; Hye-Won Na; Seung-Taek Lee; Jong Ho Park
Journal:  Cancer Sci       Date:  2013-06-13       Impact factor: 6.716

8.  Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.

Authors:  Anne-Catherine Lhoumeau; Sébastien Martinez; Jean-Marie Boher; Geneviève Monges; Rémy Castellano; Armelle Goubard; Marie Doremus; Flora Poizat; Bernard Lelong; Cécile de Chaisemartin; Florence Bardin; Patrice Viens; Jean-Luc Raoul; Thomas Prebet; Michel Aurrand-Lions; Jean-Paul Borg; Anthony Gonçalves
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

9.  PTK7 promotes the malignant properties of cancer stem-like cells in esophageal squamous cell lines.

Authors:  Jun Bie; Xin Hu; Mi Yang; Xianwei Shi; Xinping Zhang; Ziwei Wang
Journal:  Hum Cell       Date:  2020-01-01       Impact factor: 4.374

10.  Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness.

Authors:  Yansheng Liu; Jing Chen; Atul Sethi; Qing K Li; Lijun Chen; Ben Collins; Ludovic C J Gillet; Bernd Wollscheid; Hui Zhang; Ruedi Aebersold
Journal:  Mol Cell Proteomics       Date:  2014-04-16       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.